OBM Transplantation

Free Publication in 2017

Current issue: 2017 


Management of Cardiac Allograft Vasculopathy

Rama Bindu Manchikalapudi
Received: May 31, 2017; Published: September 29,2017; doi:10.21926/obm.transplant.1703005


Malignancy in the Lung Transplant Population

Sheri Tran, Mark M. Fuster
Received: July 16, 2017; Published: September 13,2017; doi:10.21926/obm.transplant.1703004

Review Article

IVIG Replacement for Hypogammaglobulinemia in Lung Transplant Patients

In Lam, Irina Gutman, Ashley Feist, Mark Mariski
Received: March 10, 2017; Published: June 22, 2017; doi:10.21926/obm.transplant.1701003


Anti-HLA Antibodies in Lung Transplantation

Gerald P. Morris
Received: February 20, 2017; Published: April 11, 2017; doi:10.21926/obm.transplant.1701002
(This article belongs to the Special Issue Lung Transplant)


OBM Transplantation—A New Hub in the Network of Transplantation Science

Pål Dag Line
Received: April 7, 2017; Published: April 11, 2017; doi:10.21926/obm.transplant.1701001

OBM Transplantation is an international peer-reviewed Open Access journal, which covers all evidence-based scientific studies related to transplantation, including: transplantation procedures and the maintenance of transplanted tissues or organs; assimilation of grafted tissue and the reconstitution of removed organs or parts of organs; transplantation of heart, lung, kidney, liver, pancreatic islets and bone marrow, etc. Areas related to clinical and experimental transplantation are also of interest.

OBM Transplantation is committed to rapid review and publication, and we aim at serving the international transplant community with high accessibility as well as relevant and high quality content.

We welcome original clinical studies as well as basic science, reviews, short reports/rapid communications, case reports, opinions, technical notes, book reviews as well as letters to the editor. 

OBM Transplantation welcomes the following types of articles: original research, review, communication, opinion, case report, comment, conference report, technical note, book review, etc. There is no restriction on the length of the papers, color figures, supplementary file types. More details please see Instructions for Authors.

Register and Submit now.

Biography of the Editor-in-Chief

Suni Pål-Dag Line graduated from the University of Oslo in 1987 and received his PhD degree from the University of Oslo in 1996. Since 2004 he has been Chairman at the Department of Surgery & Transplantation Medicine, Oslo University Hospital. He is board certified in general surgery, vascular surgery and transplant surgery. He holds the position as senior consultant surgeon and within the fields of abdominal transplantation (liver, kidney, pancreas), HPB surgery and vascular surgery as well as professor of surgery at the University of Oslo. He has a particular clinical and scientific experience and interest within the fields of living donation, abdominal vascular disease, liver transplantation, hepatocellular carcinoma, liver regeneration and immunotherapy. He is the Norwegian board member of the Scandinavian organ procurement organisation Scandiatransplant and member of the international transplantation societies TTS, ILTS and ESOT as well as the International Hepato-Pancreato-Biliary Association, European Surgical Association and International Surgical Group.